CSL Limited (ASX:CSL)
Pharmaceuticals, Biotechnology & Life Sciences
share price: (EoD)
earnings per share:
dividends per share:
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) share price news
Today's ASX news
S&P/ASX 200 Tipped To Rise
The Australian share market, or S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO), is expected to open higher on Wednesday.
February 13, 2018
Today's ASX news
CSL Limited Lifts S&P/ASX 200
CSL Limited (ASX:CSL) shares lifted Australia’s S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) on Tuesday.
February 13, 2018
Today's ASX news
Australia’s All Ordinaries Had a Bad Day
The ALL ORDINARIES (INDEXASX:XAO)(ASX:XAO) index fell 1% on Friday, as the Telstra Corporation Ltd (ASX:TLS) share price slipped 2%.
February 9, 2018
